FOR IMMEDIATE RELEASE
September 20, 2021
WASHINGTON, DC—Finnegan attorneys Robert Kramer, Gary Ma, Leslie McDonell, Charles Suh, Anthony Tridico, Ningling Wang, and Naoki Yoshida are named on the IAM Strategy 300: The World’s Leading IP Strategists list. The list identifies individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. Individuals are identified through confidential online nominations followed by face-to-face and telephone interviews with members of the global IP community.
Robert Kramer litigates complex IP and competition matters and advises leading technology companies and famous brands on their global IP strategies. For more than 25 years, Bob’s experience has spanned the fields of semiconductors, cryptography and blockchains, telecommunications and mobile phones, medical devices, pharmaceuticals and health supplements, gaming devices, sporting equipment, and consumer products. He has represented clients in numerous U.S. district courts, the U.S. Court of Appeals for the Federal Circuit, as well as at the USPTO (PTAB and TTAB), the U.S. International Trade Commission (ITC), the Federal Trade Commission (FTC), and the European Commission. In addition to litigation, Bob works with clients to create and manage international IP portfolios, negotiate complex IP disputes, draft license agreements and settlements involving all aspects of IP, and conduct IP due diligence and other internal corporate and technology investigations. Bob’s additional qualifications as an Australian solicitor (NSW) and registered trade marks attorney has proven particularly beneficial in counseling Australia-based clients with interests in the U.S. market.
Gary Ma serves as managing partner of Finnegan’s Taipei office. Named as a leader in litigation and transactions in Taiwan by Intellectual Asset Management, Gary represents clients in patent and trade secret litigations before U.S. district courts and at the ITC. His litigation experience includes arguing motions and taking multiple cases to trial. He represents and counsels clients on inter partes reviews (IPRs), reexaminations, and interference proceedings at the U.S. Patent and Trademark Office (USPTO). He also counsels clients on non-adversarial matters, including conducting freedom to operate and patentability opinions and helping clients to develop useful and valuable patent portfolios. Gary teaches classes on U.S. patent litigation at the Institute of Technology Law at National Chiao Tung University in Taiwan and presents or participates in panels at advanced intellectual property law seminars in the United States, Taiwan, and China.
Leslie McDonell has been recognized as a leader in intellectual property law by Chambers USA, World IP Review, The Legal 500 U.S., Managing Intellectual Property, and LMG Life Sciences. She provides strategic counseling to both startups and larger companies on the procurement and protection of intellectual property in the pharmaceutical and biotechnology industries. She has extensive experience in conducting due diligence investigations and preparing companies to be the target of a due diligence, pre-litigation analyses, and offensive and defensive post-grant proceedings. Leslie has represented clients before the USPTO in patent appeals, interferences, reissues, reexaminations, and IPRs. Her U.S. litigation experience includes representation of both plaintiffs and defendants in biotechnology and pharmaceutical cases. She coordinates worldwide patent portfolio strategies, evaluates and analyzes competitors’ patent positions around the world, and advises and renders opinions on issues of patentability, inventorship, validity, claim scope, infringement, and freedom-to-operate. Leslie previously served as the managing partner of Finnegan’s Boston office and currently serves as a member of the firm’s compensation committee.
Charles Suh serves as managing partner of Finnegan’s Seoul office. He practices both utility and design patent litigation before U.S. district courts and at the ITC. Charles has served as lead counsel and participates in every aspect of district court and ITC litigation, and in IPR proceedings at the Patent Trial and Appeal Board (PTAB). Charles’s experience includes formulating litigation and pre-litigation strategy, oral arguments, taking witness testimony at trial, taking and defending depositions, briefing, and day-to-day case management. As a fluent Korean speaker, Charles focuses on IP matters involving Korean companies and is experienced in Korea-specific litigation tasks, including managing discovery of evidentiary material written in Korean and preparation of Korean-speaking witnesses for deposition and trial. In addition, Charles has significant experience in patent portfolio management, preparing patentability, validity, and infringement opinions, and preparing and prosecuting patent applications directed to technical areas, including semiconductor fabrication/packaging, electronics, computer hardware/software, and military tactical systems.
Anthony Tridico, Ph.D., is managing partner of Finnegan’s London office. He has worked in Europe for most of his career, gaining significant knowledge of the European Patent Convention (EPC) and the diversity of laws and practice among the European national systems. His knowledge of the various legal systems and how they differ from similar institutions in the United States allows Anthony to effectively counsel clients across life sciences industries with global interests in intellectual property. Anthony has over 20 years of experience representing clients with a focus on patent office trials and appeals, patent prosecution management, IP due diligence and litigation. His practice includes experience in a variety of technical areas including biologics, immunology and biotechnology, chemical and pharmaceutical sciences, polymers and adhesives, food sciences, medical devices, and diagnostics and instrumentation. A significant portion of Anthony’s current practice is devoted to post-grant proceedings, appeals and oral hearings at the PTAB, as well as European Patent Office (EPO) opposition and appeal procedures.
Ningling Wang serves as the managing partner of the firm’s Shanghai office and has been recognized by World IP Review as a leader for patents in China. Her practice involves patent prosecution, opinions, due diligence, client counseling, licensing, and patent litigation in the areas of chemicals, chemical engineering, pharmaceuticals, medical devices, semiconductor materials, 3D printing, and nanotechnology. Ningling has extensive experience working with multinational and Chinese companies, providing legal advice on IP portfolio management, due diligence, licensing, litigation, and trade secret protection and enforcement. She has been involved in various cases before the ITC and U.S. district courts. She has also represented foreign companies with IP enforcement in China, including judicial and customs enforcement actions.
Naoki Yoshida, managing partner of Finnegan’s Tokyo office, handles a broad range of intellectual property matters, including litigation, patent portfolio management, intellectual property due diligence, client counseling, licensing and negotiations, patent prosecution, and pre-litigation strategic counseling. Naoki has significant experience in global intellectual property issues involving multinational corporations. With his fluency in Japanese and appreciation for cultural differences, he frequently counsels clients on unique intellectual property issues arising out of negotiations and disputes involving Japanese companies. Naoki has participated in proceedings in Japanese courts in connection with U.S. patent infringement litigation.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices all aspects of patent, trademark, and copyright law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to advertising, trade secret law, European patents and trade marks, international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn and Twitter.
October 7, 2021
October 1, 2021
October 1, 2021
September 30, 2021
September 22, 2021
September 21, 2021
September 17, 2021
September 15, 2021